mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for BTRC
Gene summary
Basic gene Info.Gene symbolBTRC
Gene namebeta-transducin repeat containing E3 ubiquitin protein ligase
SynonymsBETA-TRCP|FBW1A|FBXW1|FBXW1A|FWD1|bTrCP|bTrCP1|betaTrCP
CytomapUCSC genome browser: 10q24.32
Type of geneprotein-coding
RefGenesNM_001256856.1,
NM_003939.4,NM_033637.3,
DescriptionE3RSIkappaBF-box and WD repeats protein beta-TrCPF-box and WD-repeat protein 1BF-box/WD repeat-containing protein 1Abeta-TrCP1epididymis tissue protein Li 2apIkappaBalpha-E3 receptor subunit
Modification date20141207
dbXrefs MIM : 603482
HGNC : HGNC
Ensembl : ENSG00000166167
HPRD : 04596
Vega : OTTHUMG00000018932
ProteinUniProt: Q9Y297
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_BTRC
BioGPS: 8945
PathwayNCI Pathway Interaction Database: BTRC
KEGG: BTRC
REACTOME: BTRC
Pathway Commons: BTRC
ContextiHOP: BTRC
ligand binding site mutation search in PubMed: BTRC
UCL Cancer Institute: BTRC
Assigned class in mutLBSgeneDBC: This gene just belongs to mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID
GO:0006511ubiquitin-dependent protein catabolic process15448698
GO:0016567protein ubiquitination16885022
GO:0042752regulation of circadian rhythm15917222
GO:0043161proteasome-mediated ubiquitin-dependent protein catabolic process15917222


Top
Ligand binding site mutations for BTRC

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
R321R321QCOAD1
R403R403CSKCM1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for BTRC
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
R321R321Q-1.0680961
R403R403C-0.93642624
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for BTRC from PDB

Top
Differential gene expression and gene-gene network for BTRC
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of BTRC and the right PPI network was created from samples without mutations in the LBS of BTRC. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for BTRC
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for BTRC
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of BTRC go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS


Top
Conservation information for LBS of BTRC
Multiple alignments for Q9Y297 in multiple species
LBSAA sequence# speciesSpecies


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas